These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21057549)

  • 1. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.
    Zuckerman T; Benyamini N; Sprecher H; Fineman R; Finkelstein R; Rowe JM; Oren I
    Bone Marrow Transplant; 2011 Sep; 46(9):1226-30. PubMed ID: 21057549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes.
    Nguyen M; Eschenauer GA; Bryan M; O'Neil K; Furuya EY; Della-Latta P; Kubin CJ
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):180-4. PubMed ID: 20356699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak.
    Wiener-Well Y; Rudensky B; Yinnon AM; Kopuit P; Schlesinger Y; Broide E; Lachish T; Raveh D
    J Hosp Infect; 2010 Apr; 74(4):344-9. PubMed ID: 19783067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
    Saidel-Odes L; Polachek H; Peled N; Riesenberg K; Schlaeffer F; Trabelsi Y; Eskira S; Yousef B; Smolykov R; Codish S; Borer A
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):14-9. PubMed ID: 22173517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
    Falagas ME; Rafailidis PI; Kofteridis D; Virtzili S; Chelvatzoglou FC; Papaioannou V; Maraki S; Samonis G; Michalopoulos A
    J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.
    Borer A; Eskira S; Nativ R; Saidel-Odes L; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Infect Control Hosp Epidemiol; 2011 Dec; 32(12):1158-65. PubMed ID: 22080653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
    Kalpoe JS; Sonnenberg E; Factor SH; del Rio Martin J; Schiano T; Patel G; Huprikar S
    Liver Transpl; 2012 Apr; 18(4):468-74. PubMed ID: 22467548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
    Ben-David D; Masarwa S; Navon-Venezia S; Mishali H; Fridental I; Rubinovitch B; Smollan G; Carmeli Y; Schwaber MJ;
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):845-53. PubMed ID: 21828964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
    Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
    Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
    Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
    J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
    Lambelet P; Tascini C; Fortunato S; Stefanelli A; Simonetti F; Vettori C; Leonildi A; Menichetti F
    New Microbiol; 2017 Jul; 40(3):161-164. PubMed ID: 28513809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.
    Cohen MJ; Block C; Levin PD; Schwartz C; Gross I; Weiss Y; Moses AE; Benenson S
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):673-8. PubMed ID: 21666398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
    Bleumin D; Cohen MJ; Moranne O; Esnault VL; Benenson S; Paltiel O; Tzukert K; Mor-Yosef Levi I; Ben-Dov IZ; Levi R; Bloch A; Haviv YS
    J Infect; 2012 Oct; 65(4):318-25. PubMed ID: 22722020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
    J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
    Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.